Patents by Inventor Michael Michaud

Michael Michaud has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12268839
    Abstract: A patch pump utilizes piezoelectricity to dispense medicament from a cartridge syringe to a patient. Pump can include a plurality of piezoelectric elements that when energized cause linear motion of a pushrod that interfaces with the syringe in the cartridge to advance the syringe and dispense the medicament. The high torque generated by the piezoelectric elements is directly converted into the same amount of torque on the lead screw, so no torque increasing gear reduction system is needed and the pushrod utilized to drive the syringe can be contained within and connected directly to the motor assembly. Such a piezoelectric-based system can therefore be made smaller and with fewer moving parts than an electromagnetic motor of the same capability such that the pump has a smaller size than has heretofore been possible with prior art electromagnetic-based syringe pumps and other pumps that utilize gear reduction systems.
    Type: Grant
    Filed: September 17, 2021
    Date of Patent: April 8, 2025
    Assignee: Tandem Diabetes Care, Inc
    Inventor: Michael Michaud
  • Patent number: 12263324
    Abstract: Devices and methods for filling a medicament cartridge of a pump, including a user-wearable, ambulatory infusion pump. A device for supporting a medicament cartridge can comprise a body portion resembling a tray, with recesses disposed therein to support one or more of a cartridge body, cartridge tubing, interconnect fitting, and vial adapter. The recesses of the tray may be shaped to correspond to that component intended to be placed in its respective recess so to provide a visual indication to a user how to couple and align the various components necessary to fill the cartridge.
    Type: Grant
    Filed: February 22, 2021
    Date of Patent: April 1, 2025
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Ryan William Betts, Maxwell Aaron Hume, Philip Sven Lamb, Michael Michaud, John Charles Nadworny, William T. Trevaskis, Steven Thuan Truong
  • Patent number: 12233240
    Abstract: Disclosed herein are methods for establishing communication protocols between wireless devices in infusion pump systems. Infusion pump systems can include a number of components capable of wireless communication with one or more other components including an infusion pump, a continuous glucose monitoring (CGM) system, a smartphone or other remote consumer electronic device and/or a dedicated remote controller for the infusion pump. In order to ensure reliable communication of data, more than one component in a system can be capable of relaying data to another component.
    Type: Grant
    Filed: December 23, 2019
    Date of Patent: February 25, 2025
    Assignee: Tandem Diabetes Care, Inc.
    Inventor: Michael Michaud
  • Publication number: 20240408303
    Abstract: Disclosed herein are systems and methods for providing an alert to a user when preservative values in insulin formulations are expected to be low. Variables that affect preservative loss in insulin can be tracked by an insulin pump while insulin is being delivered by the pump. If the variables indicate that preservative values are below a threshold, an alert can be provided on the pump instructing the user to replace the insulin and/or implement another corrective action.
    Type: Application
    Filed: June 7, 2023
    Publication date: December 12, 2024
    Inventors: Michael Michaud, Adam Evard, Brendan Nichols, Francesca Shadeed
  • Patent number: 12138425
    Abstract: Disclosed herein are apparatuses and methods that account for exercise in closed loop insulin delivery systems. Rather than increasing a target insulin on board (IOB) as glucose levels rise, which would increase insulin delivery to address the raised glucose levels, when a user indicates that the user will be exercising raised glucose levels are addressed by reducing the target IOB within the closed loop algorithm. By reducing the target IOB, the algorithm responds less aggressively to pre-exercise food, and does not build up the IOB that can cause dangerously low glucose levels once the exercise also begins lowering glucose levels.
    Type: Grant
    Filed: May 20, 2020
    Date of Patent: November 12, 2024
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Thomas R. Ulrich, Michael Michaud, Geoffrey A. Kruse, Paul Harris, Garrett Marin
  • Publication number: 20240350728
    Abstract: Disclosed herein are systems and methods for mitigating the risk of insulin stacking in automated insulin delivery systems. In AID systems configured to both automatically calculate insulin delivery based on glucose levels and receive manual programming of meal boluses configured to counteract carbohydrates in a meal, insulin stacking can result if the system automatically increases insulin delivery based on a rise in glucose levels in response to consumption of a meal and the user later programs a meal bolus for the meal. The risk of such double dosing is mitigated by the systems and methods disclosed herein by enabling the system to account for recent automated insulin increases when a meal bolus is programmed.
    Type: Application
    Filed: April 18, 2023
    Publication date: October 24, 2024
    Inventors: Jacob Kearns, Michael Michaud, Geoffrey A. Kruse, Thomas R. Ulrich, Paul Harris, Scott Leas, Betsy Dokken, Garrett Marin, Nicholas Sherer
  • Publication number: 20240269383
    Abstract: Disclosed herein are apparatuses and methods incorporating an infusion pump and a CGM that can include software that automatically populates a blood glucose section of a bolus calculator with a most recent valid CGM value. The software can additionally be programmed to automatically populate the bolus calculator with a single CGM reading only when one or more predefined conditions are met that aid in mitigating the risk of inaccurate and/or invalid singleCGMreadings.
    Type: Application
    Filed: April 16, 2024
    Publication date: August 15, 2024
    Inventors: Michael MICHAUD, Garrett MARIN, Geoffrey A. KRUSE, Jacob KEARNS, Thomas R. ULRICH, Trevor DENBO, David BERGER
  • Publication number: 20240257966
    Abstract: Embodiments of the present disclosure enable a user-wearable infusion pump that may have a limited user interface including no display to be paired with a remote control device that can include a remote consumer electronic device such as a smartphone and/or a dedicated remote controller.
    Type: Application
    Filed: April 16, 2024
    Publication date: August 1, 2024
    Inventors: Jason Farnan, Zion Greenlee, Geoffrey A. Kruse, Michael Michaud
  • Publication number: 20240252741
    Abstract: A user-wearable patch pump system for delivery of insulin or other medicament can include a patch pump having a reusable drive unit and a replaceable and refillable cartridge. The cartridge can selectively attach to and be detached from the drive unit. The cartridge can initially be inserted onto the drive unit in a first orientation at an angle to the drive unit and then be rotated to align the cartridge with the drive unit and lock the cartridge in place on the drive unit to form the patch pump.
    Type: Application
    Filed: April 9, 2024
    Publication date: August 1, 2024
    Inventors: Michael Michaud, Philip Lamb, Michael Fitzgibbons
  • Publication number: 20240226423
    Abstract: Embodiments of the present disclosure relate to an infusion pump system including a holder or carrier for a user-wearable infusion pump that can be worn on the patient's body. Embodiments depicted and described herein provide a more versatile, secure, and user-friendly way to hold and carry a user-wearable infusion pump.
    Type: Application
    Filed: January 9, 2024
    Publication date: July 11, 2024
    Inventors: Jacob Pearlman, Neel Shah, Neal Johnston, Michael Michaud, Adam Evard, Eduardo Ho, Tinh Tran, Dominic Chiotti, Katalina Aguilar, Byron Cohea, Nathan Dale, Virginia Lu
  • Publication number: 20240189504
    Abstract: Embodiments disclosed herein are directed to ambulatory infusion pump systems that integrate a CGM sensor with an ambulatory infusion pump. An electrical connection can be established between the CGM sensor and the pump such that no wireless connectivity between the devices is required.
    Type: Application
    Filed: July 10, 2023
    Publication date: June 13, 2024
    Inventors: Michael Michaud, Philip Sven Lamb
  • Publication number: 20240157052
    Abstract: Apparatuses and methods for transitioning to sleep mode or otherwise modified glucose target range in automated insulin delivery systems. For example, sleep mode can include a lower glucose target and/or lower and narrower glucose target range because of fewer variables that affect glucose values during sleep such as eating and exercise. Due to increased stability provided by the sleep mode target range, it is desirable to transition to the sleep mode target range as quickly as possible, while ensuring the transition is done safely and does not risk low glucose or hypoglycemia by too quickly switching to the lower and narrower target range. Systems and methods disclosed herein therefore provide various approaches for safely and quickly transitioning to sleep mode or other modified target ranges in order to improve time in range by being more aggressive to get to the lower sleep mode or other target faster without risking hypoglycemia.
    Type: Application
    Filed: January 22, 2024
    Publication date: May 16, 2024
    Inventors: Alexandra Elena Constantin, Michael Michaud, Geoffrey A. Kruse, Thomas R. Ulrich, Paul Harris, Virginia S. Lu, Garrett Marin
  • Patent number: 11984223
    Abstract: Embodiments of the present disclosure enable a user-wearable infusion pump that may have a limited user interface including no display to be paired with a remote control device that can include a remote consumer electronic device such as a smartphone and/or a dedicated remote controller.
    Type: Grant
    Filed: October 10, 2022
    Date of Patent: May 14, 2024
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Jason Farnan, Zion Greenlee, Geoffrey A. Kruse, Michael Michaud
  • Patent number: 11969576
    Abstract: Disclosed herein are apparatuses and methods incorporating an infusion pump and a CGM that can include software that automatically populates a blood glucose section of a bolus calculator with a most recent valid CGM value. The software can additionally be programmed to automatically populate the bolus calculator with a single CGM reading only when one or more predefined conditions are met that aid in mitigating the risk of inaccurate and/or invalid single CGM readings.
    Type: Grant
    Filed: July 6, 2020
    Date of Patent: April 30, 2024
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Michael Michaud, Garrett Marin, Geoffrey A. Kruse, Jacob Kearns, Thomas R. Ulrich, Trevor Denbo, David Berger
  • Publication number: 20240123140
    Abstract: Methods and systems are disclosed wherein temperature in a device such as an ambulatory infusion pump is monitored during inductive charging of the device such that temperature-sensitive contents or components, such as, for example, insulin, particular circuitry and/or other components are not damaged. Temperature can be monitored in the device at one or more locations during inductive charging. If the temperature breaches one or more predetermined thresholds and/or is rising at a rate greater than one or more predetermined thresholds, charging can be suspended or provided at reduced power to prevent the temperature from further rising and damaging the contents and/or components of the device. One or more alerts associated with these events may also be triggered so that the user is aware of the situation and may take corrective action.
    Type: Application
    Filed: December 22, 2023
    Publication date: April 18, 2024
    Inventors: Caleb Butler, Robert Eastridge, Michael Michaud, Philip S. Lamb, Geoffrey A. Kruse
  • Publication number: 20240127923
    Abstract: Disclosed herein are systems and methods for remotely monitoring and/or controlling medical therapy of a patient. Embodiments of the current disclosure provide a remote monitoring and/or control architecture that can establish a predetermined set of permissions for real time monitoring of patient data and/or notifications and/or control of medical device therapy. The system can include permissions to determine who, how and when information and/or control is shared that can consider factors such as time, location and relationship with the patient.
    Type: Application
    Filed: December 27, 2023
    Publication date: April 18, 2024
    Inventors: Manuel Jaime, Josh Juster, Larkin Lowrey, Geoffrey A. Kruse, Garrett Marin, Michael Michaud
  • Patent number: 11951284
    Abstract: Apparatuses and methods for transitioning to sleep mode or otherwise modified glucose target range in automated insulin delivery systems. For example, sleep mode can include a lower glucose target and/or lower and narrower glucose target range because of fewer variables that affect glucose values during sleep such as eating and exercise. Due to increased stability provided by the sleep mode target range, it is desirable to transition to the sleep mode target range as quickly as possible, while ensuring the transition is done safely and does not risk low glucose or hypoglycemia by too quickly switching to the lower and narrower target range. Systems and methods disclosed herein therefore provide various approaches for safely and quickly transitioning to sleep mode or other modified target ranges in order to improve time in range by being more aggressive to get to the lower sleep mode or other target faster without risking hypoglycemia.
    Type: Grant
    Filed: August 27, 2021
    Date of Patent: April 9, 2024
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Alexandra Elena Constantin, Michael Michaud, Geoffrey A. Kruse, Thomas R. Ulrich, Paul Harris, Virginia S. Lu, Garrett Marin
  • Patent number: 11872368
    Abstract: Methods and systems are disclosed wherein temperature in a device such as an ambulatory infusion pump is monitored during inductive charging of the device such that temperature-sensitive contents or components, such as, for example, insulin, particular circuitry and/or other components are not damaged. Temperature can be monitored in the device at one or more locations during inductive charging. If the temperature breaches one or more predetermined thresholds and/or is rising at a rate greater than one or more predetermined thresholds, charging can be suspended or provided at reduced power to prevent the temperature from further rising and damaging the contents and/or components of the device. One or more alerts associated with these events may also be triggered so that the user is aware of the situation and may take corrective action.
    Type: Grant
    Filed: April 10, 2019
    Date of Patent: January 16, 2024
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Caleb Butler, Robert Eastridge, Michael Michaud, Philip S. Lamb, Geoffrey A. Kruse
  • Patent number: 11869650
    Abstract: Disclosed herein are systems and methods for remotely monitoring and/or controlling medical therapy of a patient. Embodiments of the current disclosure provide a remote monitoring and/or control architecture that can establish a predetermined set of permissions for real time monitoring of patient data and/or notifications and/or control of medical device therapy. The system can include permissions to determine who, how and when information and/or control is shared that can consider factors such as time, location and relationship with the patient.
    Type: Grant
    Filed: January 12, 2022
    Date of Patent: January 9, 2024
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Manuel Jaime, Josh Juster, Larkin Lowrey, Geoffrey A. Kruse, Garrett Marin, Michael Michaud
  • Patent number: D1010816
    Type: Grant
    Filed: December 3, 2021
    Date of Patent: January 9, 2024
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Steven B. Cook, Philip Sven Lamb, Ryan William Betts, Michael Michaud